全球前列腺癌发病与死亡的最新模式与趋势:一项更新
该研究基于2022年GLOBOCAN估计及癌症发病五大洲系列和世界卫生组织死亡数据库,分析各国前列腺癌年龄标化发病与死亡率的模式和趋势。结果显示2022年不同区域发病率相差13倍、死亡率相差9.5倍;近5年50个国家中11个发病率上升、59个国家中9个死亡率上升。
要点
- 2022年全球前列腺癌发病率区域间相差13倍,死亡率相差9.5倍。
- 发病率最高在澳大利亚/新西兰、北美、北欧和拉丁美洲/加勒比地区。
- 死亡率最高在撒哈拉以南非洲和拉丁美洲/加勒比地区。
核心结论
- 非洲、亚洲和拉丁美洲/加勒比地区许多国家前列腺癌发病率和死亡率上升,可能分别与检出增加(发病率)和治疗可及性有限(仅死亡率)有关。
- 研究结果强调改善这些国家卫生保健基础设施以减轻前列腺癌负担的重要性。
研究设计与样本
- 分析2022年GLOBOCAN估计的各国和各区域前列腺癌年龄标化发病率和死亡率。
- 使用癌症发病五大洲系列和世界卫生组织死亡数据库分析50个国家和地区的发病率趋势及59个国家和地区的死亡率趋势。
主要发现
- 2022年估计前列腺癌发病率区域间相差13倍,死亡率区域间相差9.5倍。
- 发病率最高在澳大利亚/新西兰、北美、北欧和拉丁美洲/加勒比地区。
- 死亡率最高在撒哈拉以南非洲和拉丁美洲/加勒比地区。
- 最近5年期间,纳入研究的50个国家中11个发病率上升,59个国家中9个死亡率上升。
- 死亡率在38个国家下降,主要集中在欧洲、大洋洲和拉丁美洲/加勒比地区。
临床怎么用
- 原文未据此给出推荐。
局限性
- 局限性包括缺乏低收入和中等收入国家的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Our aim was to examine worldwide patterns and trends for prostate cancer (PC) incidence and mortality using high-quality, up-to-date, population-based data. METHODS: We analyzed age-standardized PC incidence and mortality rates by country and region from the 2022 GLOBOCAN estimates and temporal trends in incidence (50 countries/territories) and mortality (59 countries/territories) rates using data from the Cancer Incidence in Five Continents series and the World Health Organization mortality database. KEY FINDINGS AND LIMITATIONS: Estimated PC rates across regions in 2022 varied 13-fold for incidence and 9.5-fold for mortality. The highest incidence rates were in Australia/New Zealand, North America, Northern Europe, and Latin America/Caribbean. The highest mortality rates were in sub-Saharan Africa and Latin America/Caribbean. During the most recent 5-yr period, incidence rates increased in 11 of the 50 countries included in the study and mortality rates increased in nine of 59 countries, mostly located in Africa, Asia, Latin America/Caribbean, and Central and Eastern Europe. Mortality rates decreased in 38 countries, largely located in Europe, Oceania, and Latin America/Caribbean. Limitations include the lack of data for low- and middle-income countries. CONCLUSIONS AND CLINICAL IMPLICATIONS: The increase in PC incidence and mortality rates in many countries in Africa, Asia, and Latin America/Caribbean may be because of increases in detection (incidence) and limited access to and availability of treatments (mortality only). The findings reinforce the importance of improving the health care infrastructure in these countries to mitigate the rising burden of PC.
引用
- Schafer EJ, Laversanne M, Sung H, et al. Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. Eur Urol. 2024. PMID: 39668103. doi:10.1016/j.eururo.2024.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。